Notice: 函数 WP_Styles::add 的调用方法不正确。 The style with the handle "storefront-woocommerce-style" was enqueued with dependencies that are not registered: storefront-style. 请查阅调试 WordPress来获取更多信息。 (这个消息是在 6.9.1 版本添加的。) in /wordpress/wp-includes/functions.php on line 6260

KC-0388

Ba/F3 AXL Cell Line

Home » Ba/F3 AXL Cell Line

Background of Ba/F3 AXL Cell Line

AXL is a transmembrane receptor tyrosine kinase, belonging to the TAM kinase family. AXL is expressed in bone marrow, myeloid cells, also found in tumor cells and tumor vasculature. The interaction with its ligand GAS6 can stimulate cell proliferation and survival. AXL has been implicated as a cancer diver gene and its expression level is correlated with the prognosis of several aggressive tumors.
Ba/F3 cell, a murine interleukin-3 dependent pro-B cell line, is a popular system for exploring both kinases and their inhibitors, because some protein kinases can render the Ba/F3 cells to be depended on the activation of the kinases instead of IL-3 supplement, while their inhibitors can antagonize the kinase-dependent growth effects.

Specifications

Catalog Number:
KC-0388
Cell Line Name:
Ba/F3-AXL-Cell-Line
Clone Number
Host Cell Line:
Ba/F3
Description:
Stable Ba/F3 clone expressing exogenous AXL gene.
Quantity:
Two vials of frozen cells (2-5×106/vial)
Stability:
Stable in culture over a minimum of 10 passages
Application:
Drug screening and biological assays
Freezing Medium:
70% RPMI1640+20% FBS+10% DMSO
Propagation Medium:
RPMI1640+10%FBS+100ng/mL Gas6
Selection Marker:
Puromycin
Morphology:
Mostly single, round (some polymorph) cells in suspension
Subculture:
Split saturated culture 1:10 every 3 days; seed out at about 1-3 × 105 cells/mL
Incubation:
37 °C with 5% CO2
Storage:
Liquid nitrogen immediately upon receiving
Doubling Time:
Approximately 20 hours
Mycoplasma Status:
Negative
In Vivo Validation:
NA

Cell Line Generation

Ba/F3 AXL cell Line was generated using retrovirus vector expressing human AXL sequence.

Characterization

Figure: Characterization of AXL overexpressing in Ba/F3 stable clones.

Figure 1:
1. Harvest and seed the Ba/F3 cells in 96-well plate (3000 cells/90μL medium).
2. Next day, add 10μL 10× serially diluted compound solution each well and incubate the plates for another 72 hours.
3. Add 100μL Cell Titer-Glo each well, mixed and readout using Envision.
4. Plot the dose-responsive curve and fit the IC50 (the centration of 50% inhibition of DMSO vehicle treated clones) using GraphPad Prism software (Version 5).

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 + 10% FBS)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:10 every 3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI-1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Wilson, C, X Ye, T Pham, E Lin, S Chan, E McNamara, R M Neve, et al. 2014. “AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs.” Cancer Research 74 (20): 5878–90.
  2. Brand, Toni M, Mari Iida, Kelsey L Corrigan, Cara M Braverman, John P Coan, Bailey G Flanigan, Andrew P Stein, et al. 2017. “The Receptor Tyrosine Kinase AXL Mediates Nuclear Translocation of the Epidermal Growth Factor Receptor.” Sci. Signal. 10 (460). American Association for the Advancement of Science: eaag1064.